Exhibit 31.2

CERTIFICATIONS
______________

I, Edward J. Weisberger, certify that:

  1.   I  have  reviewed this quarterly report on Form 10-Q of  IGENE
  Biotechnology, Inc.;

  2.   Based  on  my  knowledge, t his report does  not  contain  any
  untrue  statement  of a material fact or omit to state  a  material
  fact  necessary  to  make the statements  made,  in  light  of  the
  circumstances   under  which  such  statements   were   made,   not
  misleading with respect to the period covered by this report;

  3.   Based  on my  knowledge, the financial statements,  and  other
  financial  information included in this report, fairly  present  in
  all   material  respects  the  financial  condition,   results   of
  operations  and cash flows of the registrant as of,  and  for,  the
  periods presented in this report;

  4.   The  registrant's  other   certifying  officer(s)  and  I  are
  responsible  for  establishing and maintaining disclosure  controls
  and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-
  15(e))  and  internal control over financial reporting (as  defined
  in  Exchange  Act Rules 13a-15(f) and 15d-15(f) for the  registrant
  and have:

          a.   Designed  such disclosure controls and procedures,  or
          caused  such  disclosure  controls  and  procedures  to  be
          designed  under  our supervision, to ensure  that  material
          information  relating  to  the  registrant,  including  its
          consolidated  subsidiaries, is made known to us  by  others
          within  those entities, particularly during the  period  in
          which this report is being prepared;

          b.    Designed   such  internal  control   over   financial
          reporting,  or caused such internal control over  financial
          reporting to be designed under our supervision, to  provide
          reasonable assurance regarding the reliability of financial
          reporting  and the preparation of financial statements  for
          external  purposes  in accordance with  generally  accepted
          accounting principles;

          c.    Evaluated   the  effectiveness  of  the  registrant's
          disclosure  controls and procedures and presented  in  this
          report  our  conclusions  about the  effectiveness  of  the
          disclosure  controls and procedures, as of the end  of  the
          period covered by this report based on such evaluation; and

          d.  Disclosed in this report any change in the registrant's
          internal  control  over financial reporting  that  occurred
          during  the  registrant's most recent fiscal  quarter  (the
          registrant's fourth fiscal quarter in the case of an annual
          report)  that  has  materially affected, or  is  reasonably
          likely  to  materially  affect, the  registrant's  internal
          control over financial reporting; and

  5.   The small business issuer's other certifying officer(s) and  I
  have  disclosed,  based on our most recent evaluation  of  internal
  control  over  financial reporting, to the small business  issuer's
  auditors  and  the  audit committee of the small business  issuer's
  board   of   directors  (or  persons  performing   the   equivalent
  functions):

          a.  All significant deficiencies and material weaknesses in
          the  design or operation of internal control over financial
          reporting  which are reasonably likely to adversely  affect
          the  registrant's ability to record, process, summarize and
          report financial information; and

          b.   Any  fraud,  whether  or not material,  that  involves
          management  or other employees who have a significant  role
          in   the   registrant's  internal  control  over  financial
          reporting.

Date: May 14, 2010

/S/ EDWARD J. WEISBERGER
_____________________________
    EDWARD J. WEISBERGER
    Chief Financial Officer